New RCT shows no benefit from probiotics, xylitol chewing gum in alleviating sore throats

December 18, 2017, Canadian Medical Association Journal

The use of probiotics and xylitol chewing gum to alleviate sore throat symptoms—as an alternative to antibiotics—appears to have no effect, according to a randomized controlled trial (RCT) published in CMAJ (Canadian Medical Association Journal).

"Simple over-the-counter treatments could potentially limit the effects of both bacterial and and help patients to manage symptoms," says Dr. Paul Little, Primary Care Group, University of Southampton, Southampton, United Kingdom. "This would enable self-management, potentially facilitate a quicker return to normal activities, and reduce the pressure to use antibiotics."

Evidence exists that indicates probiotics and xylitol, a birch sugar that prevents bacterial growth, can help reduce recurrence of upper .

The study included 934 people in the UK during the four year study period (June 2010 to 2014), of whom 689 provided complete data for the trial. Using a diary, participants reported the number of probiotic capsules and sticks of chewing gum used each day, as well as the severity of symptoms. They were study "compliant" if they had taken 75% of their allotted treatment.

Researchers found no significant effect of either probiotics or xylitol on sore throat (pharyngitis) symptoms.

"There were no significant differences between groups for both the and the probiotic groups, which suggests that neither intervention helped in controlling acute symptoms," the authors write.

The study is one of only a few that looks at the effectiveness of two potentially useful alternative therapies for acute sore throats.

"There is no reason for clinicians to advise patients to use either of these treatments for the symptomatic management of pharyngitis," they conclude.

The study was conducted by researchers from the University of Southampton, Southampton, UK, with a patient collaborator.

Explore further: Study examines effectiveness of steroid medication for sore throat

More information: Paul Little et al. Probiotic capsules and xylitol chewing gum to manage symptoms of pharyngitis: a randomized controlled factorial trial, Canadian Medical Association Journal (2017). DOI: 10.1503/cmaj.170599

Related Stories

Study examines effectiveness of steroid medication for sore throat

April 18, 2017
In patients with a sore throat that didn't require immediate antibiotics, a single capsule of the corticosteroid dexamethasone didn't increase the likelihood of complete symptom resolution after 24 hours, and although more ...

Steroids not effective for chest infections in non-asthmatic adults

August 22, 2017
Oral steroids should not be used for treating acute lower respiratory tract infection (or 'chest infections') in adults who don't have asthma or other chronic lung disease, as they do not reduce the duration or severity of ...

Recommending oral probiotics doesn't cut antibiotic use

September 16, 2016
(HealthDay)—Advising patients with asthma to take probiotics does not reduce antibiotic use, according to a study published in the September/October issue of the Annals of Family Medicine.

Tonsillectomy in adults with severe recurrent sore throats may benefit some people

April 2, 2013
Tonsillectomy may result in fewer severe sore throats and could benefit some adult patients, according to a randomized trial published in CMAJ (Canadian Medical Association Journal).

Ibuprofen no good in treating colds or sore throats

November 4, 2013
Questions have been raised about the advice given to patients with a cold and sore throat, in research published in the British Medical Journal.

New test for patients with sore throats cuts antibiotic use by nearly a third

November 8, 2013
A new 'clinical score' test for patients with sore throats could reduce the amount of antibiotics prescribed and result in patients feeling better more quickly, research in the British Medical Journal shows.

Recommended for you

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.